MENOMUNE-A/C/Y/W-135
SANOFI PASTEUR LIMITED
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is MENOMUNE-A/C/Y/W-135 discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that MENOMUNE-A/C/Y/W-135 50 μG 50 μG 50 μG 50 μG has been permanently discontinued (last updated March 30, 2017). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is MENOMUNE-A/C/Y/W-135 not available?
The reason the manufacturer reported: Business reasons.
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
01959018
Strength
50 μG 50 μG 50 μG 50 μG
Dosage Form
Powder For Solution
Route
INTRAMUSCULAR
Active Ingredient
MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP A MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP C MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP W-135 MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP Y
Compare with another product →